ClassID:

91740

C07C50/24 - CPC Classification

Classification description:

Quinones containing halogen

Recent Application in this class:
#1
20250387359
2025-12-25

COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS

#2
20250270158
2025-08-28

PROCESS FOR PREPARING TAPINAROF

#3
20230174445
2023-06-08

Process for preparing tapinarof

#4
20230097854
2023-03-30

METHODS FOR CONVERTING THC-RICH CANNABINOID MIXTURES INTO CBN-RICH CANNABINOID MIXTURES

#5
20220313631
2022-10-06

COMPOUNDS AND METHODS FOR THE TREATMENT OF PARASITIC INFECTIONS

#6
20220177442
2022-06-09

Methods for converting THC-rich cannabinoid mixtures into CBN-rich cannabinoid mixtures

#7
20210238119
2021-08-05

Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

#8
20210163388
2021-06-03

Process for preparing tapinarof

#9
20210024442
2021-01-28

Process for preparing tapinarof

#10
20200331835
2020-10-22

Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

#11
20190144367
2019-05-16

Process for preparing tapinarof

#12
20180370892
2018-12-27

Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

#13
20180258217
2018-09-13

Quantitative intramolecular fission in oligoacenes, materials, and methods of use thereof

#14
20180105506
2018-04-19

Tocopherol and tocopheryl quinone derivatives as correctors of lysosomal storage disorders

#15
20160244392
2016-08-25

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#16
20160207902
2016-07-21

Tocopherol and tocopheryl quinone derivatives as correctors of Lysosomal Storage Disorders

#17
20150141415
2015-05-21

Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases

#18
20140121238
2014-05-01

Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents

#19
20110144347
2011-06-16

PROCESS FOR THE EPIMERIZATION OF ATOVAQUONE ISOMER, ATOVAQUONE INTERMEDIATES AND MIXTURE THEREOF

#20
20110059972
2011-03-10

1,4-naphthoquinones derivatives and therapeutic use thereof

#21
20110004024
2011-01-06

Preparation of naphthoquinone compounds using 2,3-dihalonaphthoquinone

#22
20100222436
2010-09-02

Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#23
20100081847
2010-04-01

Process for preparation of atovaquone and novel intermediates thereof

#24
20090261300
2009-10-22

Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same

#25
20090176773
2009-07-09

Non-Peptidic Inhibitors of AKAP/PKA Interaction

#26
20070225261
2007-09-27

Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#27
20070208086
2007-09-06

UBIQUINONE ANALOGS AND METHODS OF USE

#28
20070203080
2007-08-30

New Drug Delivery System for Crossing the Blood Brain Barrier

#29
20060281809
2006-12-14

Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

#30
20050288522
2005-12-29

Process for preparing pentacene derivatives

#31
20050070744
2005-03-31

Process for conversion of phenol to hydroquinone and quinones